Klf5 (also known as BTEB2 and IKLF), a member of the Kruppel-like family of transcription factors, has been implicated as an oncogene and therapeutic target in a number of cancers, including breast, colon, bladder, lung, stomach, and ovarian cancer [47]. This evidence concerns the gene KLF5 and ovarian carcinoma.